Prolyl hydroxylase-3 is a novel renal cell carcinoma biomarker.
Kwang Hyun KimHyung Ho LeeYoung-Eun YoonJoon Chae NaKyung Sup KimWoong Kyu HanPublished in: Investigative and clinical urology (2019)
Serum PHD3 represents a novel RCC biomarker that shows acceptable diagnostic performance.
Keyphrases